| Trial Identifier: | D1690R00030 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT02971618 |
| Start Date: | February 2017 |
| Primary Completion Date: | August 2018 |
| Condition: | Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Russia | Saint Petersburg, Russia |
| Russia, Russia | Moscow, Russia, Russia |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company